<?xml version="1.0" encoding="UTF-8"?>
<p>The design of our study, which is–to the best of our knowledge–the first comprehensive prospective study presenting the daily evolution of clinical and laboratory findings in HFRS, has enabled assessment of the proportion of patients with individual signs/symptoms/laboratory abnormalities present on each day of illness (
 <xref ref-type="supplementary-material" rid="pone.0197661.s002">S2</xref> and 
 <xref ref-type="supplementary-material" rid="pone.0197661.s003">S3</xref> Figs). The study also allowed evaluation of the onset, duration, and magnitude of several clinical signs/symptoms and laboratory abnormalities (Tables 
 <xref ref-type="table" rid="pone.0197661.t002">2</xref> and 
 <xref ref-type="table" rid="pone.0197661.t003">3</xref>). Our results showed that the classic evolution through five distinct phases (febrile, hypotensive, oliguric, polyuric, and convalescent) is often unclear.
</p>
